In a phase I human clinical trial, replication-defective adenovirus encoding ISF35 (Ad-ISF35), a recombinant CD154 transgene, was used ex vivo to transduce chronic lymphocytic leukemia (CLL) cells. The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.